Skip to Content
Here are the worst-performing U.S. stocks on Tuesday
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Astellas Announces the Approval of XTANDI® (enzalutamide) by the China National Medical Products Administration (NMPA)
Akcea, Ionis Close Licensing Agreement with Pfizer on New Drug
Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx)
Pfizer: FDA Approves Humira Biosimilar Abrilada for Multiple Conditions
FDA Approves Pfizer’s Biosimilar, ABRILADA™ (adalimumab-afzb) for Multiple Inflammatory Conditions
Bristol-Myers Squibb and Pfizer Announce Randomized, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals
CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.
Mylan and Pfizer Say Combined Mylan-Upjohn to Be Called Viatris
